FindMyRecallSubscribe
Class II: temporary or reversible health riskOngoing

Wellness BioSciences CBD Metered Dose Inhaler Recall

CBD Metered Dose Inhaler (CBD) 5 mg Dose, 1 Metered Dose Inhaler, 100 Metered Sprays,…

Wellness BioSciences · Houston, TX

Risk level
Class II
Reported by FDA
May 3, 2023
Recall ID
D-0541-2023
Check your lot numberHow we source this data

Summary

Wellness BioSciences recalled CBD Metered Dose Inhaler starting Apr 1, 2022. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0541-2023 on May 3, 2023. Reason: Marketed Without an Approved NDA/ANDA. Status: Ongoing.

Why it was recalled

Marketed Without an Approved NDA/ANDA

Product description

CBD Metered Dose Inhaler (CBD) 5 mg Dose, 1 Metered Dose Inhaler, 100 Metered Sprays, Wellness BioSciences Rx

Lot numbers, UPCs & expiration codes

All lots

Where it was sold

Nationwide within the United States

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0541-2023
Classification
Class II
Status
Ongoing
Recall initiated
Apr 1, 2022
FDA report date
May 3, 2023
Quantity
2000 inhalers
Recall type
Voluntary: Firm initiated
Recalling firm
Wellness BioSciences

Original FDA data

Every field from FDA enforcement report D-0541-2023, exactly as published.

Show all FDA fields
City
Houston
State
TX
Status
Ongoing
Country
United States
Event ID
92089
Address
9789 Katy Fwy Apt 1801
Code information
All lots
Postal code
77024-1378
Report date
May 3, 2023
Product type
Drugs
Recall number
D-0541-2023
Classification
Class II
Recalling firm
Wellness BioSciences
Product quantity
2000 inhalers
Reason for recall
Marketed Without an Approved NDA/ANDA
Voluntary / mandated
Voluntary: Firm initiated
Product description
CBD Metered Dose Inhaler (CBD) 5 mg Dose, 1 Metered Dose Inhaler, 100 Metered Sprays, Wellness BioSciences Rx
Distribution pattern
Nationwide within the United States
Recall initiation date
Apr 1, 2022
Initial firm notification
Other
Center classification date
Apr 21, 2023

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0541-2023, published May 3, 2023. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls